(R,R)-N,N’-Bis(3,5-Di-Tert-Butylsalicylidene)-1,2-Cyclohexanediaminocobalt(II)
| Purity | Grade | Package | Stock | Price | Quantity |
|---|---|---|---|---|---|
| 98% | RG | 1G | In Stock | 4 USD | |
| 98% | RG | 5G | In Stock | 9 USD | |
| 98% | RG | 25G | In Stock | 22 USD | |
| 98% | RG | 100G | In Stock | 113 USD | |
| 98% | RG | 500G | In Stock | 545 USD | |
|
Should you have any questions, please contact us by Email. |
|||||
Applications of 176763-62-5
(R,R)-N,N'-Bis(3,5-di-tert-butylsalicylidene)-1,2-cyclohexanediaminocobalt(II) finds applications in:
- Catalysis: It serves as an effective catalyst for various asymmetric reactions, making it valuable in synthetic organic chemistry.
- Research: The compound is used in academic and industrial research settings to study reaction mechanisms and develop new synthetic methodologies.
- Pharmaceutical Development: Its ability to produce chiral intermediates makes it useful in pharmaceutical synthesis where chirality is crucial for drug efficacy.
NMR spectrum of 176763-62-5
Safety Information of 176763-62-5
Download COA of 176763-62-5
Bulk Packaging Price Explanation of 176763-62-5
Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.
Purchase Instructions of 176763-62-5
All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.
These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.
Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.
New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.

